ISIN

US74319F4046

Biora Therapeutics Inc

Get an email when a new filing names US74319F4046. A free account follows up to three names.Create a free account →

US74319F4046 in the last 90 days

Biora Therapeutics Inc (US74319F4046) has 1 named short position on the German register (Bundesanzeiger), adding up to 0.89% of issued capital.

  • Registers: named positions add up to 0.89% of issued capital. Positions from 0.1% are reported to the regulator; the holder is named from 0.5%.
  • Delay: each filing below shows how many days passed between the trade and its publication. None of this is real-time.

Latest filing on file: — · public filings, reported as filed

What the filings show

What the filings show · last 90 days · Quiet Money indicator

1 of 4 sources

-18Tilted out

Leaning outBalancedLeaning in

The disclosed money is leaning away from this name, on what has actually been filed. This reads on one source only, so treat it lightly.

EU net short
1 holder disclose 0.89% of issued capital held short in named positions. Holders are named from 0.5%; positions from 0.1% go to the regulator, so the full total can be higher.
-18

This summarises filings that have already been published — it is not a forecast, a rating of the company, or advice. Every figure above is listed in full further down this page, with the document it came from.

Named short positions, combined

0.89%of issued capital · 1 holder

Holders are named from 0.5%. Positions from 0.1% are reported to the regulator but not published, so the full total can be higher.

On file here

Short positions1

Insider purchases0

US House transactions0

Latest change05 DEC 2024

SHORT POSITIONS · 1INSIDER BUYS · 0US HOUSE · 0
Position holderDisclosedDated
Squarepoint Ops LLC0.89%05 DEC 2024

Source — Bundesanzeiger · Netto-Leerverkaufspositionen →Register of current open positions

What this page will never showNo buy or sell ratingsNo price targetsNo forecastsIndicators are rules-based summaries of the filingsDocuments, dates, and how long they took to become public.